Tuesday, August 22, 2023 11:15:41 PM
Legend431,
Merck has been awful quiet about their interest in NWBO since Mr. Duffy returned to them and then went to Regeneron who was represented at NYAS on May 10th last year. Seems Mr. Duffy learned something so important that NO ONE IS TALKING! Do you suppose Merck and Regeneron might be vetted by NWBO and all are just waiting on final clearance for takeoff?; ). Maybe some others suspect the same and aren’t happy with the way things are headed. See any issue with Pfizer, Biden administration and Citadel reps hanging out together with the Bilderbergs this year or Kenny donating all that money to Harvard?: (. Can anyone else see the light?; ). Best wishes.
Merck has been awful quiet about their interest in NWBO since Mr. Duffy returned to them and then went to Regeneron who was represented at NYAS on May 10th last year. Seems Mr. Duffy learned something so important that NO ONE IS TALKING! Do you suppose Merck and Regeneron might be vetted by NWBO and all are just waiting on final clearance for takeoff?; ). Maybe some others suspect the same and aren’t happy with the way things are headed. See any issue with Pfizer, Biden administration and Citadel reps hanging out together with the Bilderbergs this year or Kenny donating all that money to Harvard?: (. Can anyone else see the light?; ). Best wishes.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
